Real-time polymerase chain reaction detection of asymptomatic Clostridium difficile colonization and rising C. difficile-associated disease rates.
about
Recent Advances in the Diagnosis and Treatment of Clostridium Difficile InfectionUltrasensitive Detection and Quantification of Toxins for Optimized Diagnosis of Clostridium difficile InfectionAntimicrobial Stewardship: How the Microbiology Laboratory Can Right the ShipActive and Secretory IgA-Coated Bacterial Fractions Elucidate Dysbiosis in Clostridium difficile InfectionClostridium difficile infection in inflammatory bowel disease: challenges in diagnosis and treatment.Clostridium difficile Infection and Fecal Microbiota Transplant.Asymptomatic carriers of toxigenic C. difficile in long-term care facilities: a meta-analysis of prevalence and risk factorsStructural and functional changes within the gut microbiota and susceptibility to Clostridium difficile infection.Development and Validation of Digital Enzyme-Linked Immunosorbent Assays for Ultrasensitive Detection and Quantification of Clostridium difficile Toxins in StoolCharacteristics and Antibiotic Use Associated With Short-Term Risk of Clostridium difficile Infection Among Hospitalized PatientsRising Stakes for Health Care-Associated Infection Prevention: Implications for the Clinical Microbiology LaboratoryOverdiagnosis of Clostridium difficile Infection in the Molecular Test Era.Challenges and opportunities in the management of Clostridium difficile infection.Homogeneous and digital proximity ligation assays for the detection of Clostridium difficile toxins A and B.Colonization with toxinogenic C. difficile upon hospital admission, and risk of infection: a systematic review and meta-analysis.New molecular diagnostic tools in traveller's diarrhea.A High Rate of Alternative Diagnoses in Patients Referred for Presumed Clostridium difficile Infection.Cadazolid for the treatment of Clostridium difficile.Challenges in fecal donor selection and screening for fecal microbiota transplantation: A review.Optimizing the diagnostic testing of Clostridium difficile infection.Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection: A Randomized Trial.Host response to Clostridium difficile infection: Diagnostics and detection.Strategies for Optimizing the Diagnostic Predictive Value of Clostridium difficile Molecular Diagnostics.The Use of a Computerized Provider Order Entry Alert to Decrease Rates of Clostridium difficile Testing in Young Pediatric Patients.Point-Counterpoint: What Is the Optimal Approach for Detection of Clostridium difficile Infection?Detection of Clostridium difficile in Feces of Asymptomatic Patients Admitted to the Hospital.Failure of Risk-Adjustment by Test Method for C. difficile Laboratory-Identified Event Reporting.Using Multiplex Molecular Testing to Determine the Etiology of Acute Gastroenteritis in Children.Diagnosing Clostridium difficile-associated diarrhea using enzyme immunoassay: the clinical significance of toxin negativity in glutamate dehydrogenase-positive patientsResponse to Prior and Fitzpatrick.Identification of Clostridium difficile Asymptomatic Carriers in a Tertiary Care Hospital.Interventions to reduce the incidence of hospital-onset Clostridium difficile infection: An agent-based modeling approach to evaluate clinical effectiveness in adult acute care hospitals.Understanding Clostridium difficile Colonization.Searching for a potential algorithm for Clostridium difficile Testing at a Tertiary Care Hospital: Does Toxin Enzyme Immunoassay Testing help?Outcomes associated with Clostridium difficile infection in patients with chronic liver disease.Clostridium difficile stool shedding in infants hospitalized in two neonatal intensive care units is lower than previous point prevalence estimates using molecular diagnostic methods.
P2860
Q26766112-3F157E5D-DCAF-4178-A2ED-D8F903A5077CQ26776411-04199E15-BF64-47BF-B7B0-FC56B0CFA646Q28068503-08AC6D6A-8633-427C-B054-B3B651D21CB3Q28829566-E8DE249B-B9B1-4BCB-9F90-5B0F0CDA7A1CQ30235905-D4D985BA-89FD-4B8C-BAAD-E6CB587F3196Q30240065-BEA7BD20-1835-45EE-B88F-0F0BD0D47DD3Q35112873-38FDAD50-C1E6-4DF1-BE47-6F81E9E34539Q36018079-B9B6C1ED-63DF-4B52-8BA9-0FF235200453Q36066827-5696697F-F0D3-442C-9CFC-5755F6B3B6A1Q36240111-39BCF59F-27E0-49EF-858C-3ED35ACE0A18Q36260465-ED23870D-B9CD-4221-BE61-339719CD5F70Q37103258-5E05CE67-8B63-46D4-8095-3A27E428F919Q38228162-EB7BAA87-D58C-4FDE-A976-A2FFFE6D6967Q38289720-0D8DE6B5-DEA9-4C4C-8958-843DB13CA38FQ38366858-2A92FCEB-2C8C-450E-B4F9-21616B71D818Q38557626-9926B78A-CFF4-41FA-9A7D-825F6F24E499Q38632748-98896B97-48CB-4FCC-8DDC-1F8D5E1F72D1Q38746746-BD11FD27-59A9-41B0-BBB4-DABE08C0EF4BQ38764998-A6C26B43-C9FC-4793-91B1-2A8F8EF43DA5Q38909959-663F364A-CBD0-46FF-B561-4E868B375606Q38933717-E2790902-851B-4B3D-9E2F-552E930E5E9AQ38969987-1AAAC40A-B047-40D1-978A-9298796DB5DDQ40302301-01221A56-4DC5-44C9-9627-A6B0BC50EC94Q40325117-67A1DA55-F0B8-4917-9353-EB79E9E12330Q40375743-433A1E90-3255-47D1-BEDA-0595A7484551Q40449224-564553E1-C9F5-43F0-8D5B-4B12CD88F554Q40505285-1B927DC6-CA8A-4E54-BD43-3857D14E882AQ40688818-01F52F1A-3DE6-435A-9F5A-95029AF9F897Q42744751-2387A39B-197D-4109-A083-ADCC2A337BBFQ43832194-EFA9FEC4-6076-4B1A-88D3-2B4539DCCC26Q44593155-C54023E2-45D4-4C81-98DE-63A60540C9FFQ47372442-0BD4C019-6BA3-4395-A877-37345EC38FEAQ52802841-19301EAF-0A93-4C52-92B3-E6E444A49CE5Q54216867-14AA7967-F521-48E5-9B5D-4A4E936678D8Q54217863-2388F5E1-F38D-4BDE-9EB1-DC91A763289BQ54236237-18C84659-EA68-4474-822D-98ABB988BE4C
P2860
Real-time polymerase chain reaction detection of asymptomatic Clostridium difficile colonization and rising C. difficile-associated disease rates.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Real-time polymerase chain rea ...... cile-associated disease rates.
@en
Real-time polymerase chain rea ...... cile-associated disease rates.
@nl
type
label
Real-time polymerase chain rea ...... cile-associated disease rates.
@en
Real-time polymerase chain rea ...... cile-associated disease rates.
@nl
prefLabel
Real-time polymerase chain rea ...... cile-associated disease rates.
@en
Real-time polymerase chain rea ...... cile-associated disease rates.
@nl
P2093
P2860
P356
P1476
Real-time polymerase chain rea ...... cile-associated disease rates.
@en
P2093
Carolyn Z Grimes
Claudia A Kozinetz
Diana C Koo
Hoonmo L Koo
John N Van
Meina Zhao
Paula A Revell
Todd Lasco
Zhi-Dong Jiang
P2860
P304
P356
10.1086/676433
P577
2014-04-22T00:00:00Z